BIOMAT Database Logo BIOMAT Database Logo

Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. 2002

Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

Two distinct subtypes of angiotensin (Ang) II receptors, type 1 (AT(1)) and type 2 (AT(2)), have been identified. Vascular smooth muscle cells (VSMCs) usually express AT(1) receptor. To elucidate the direct effects of the AT(2) receptor on the AT(1) receptor in VSMCs, we transfected AT(2) receptor gene into cultured rat VSMCs. Overexpression of AT(2) receptor significantly decreased expression of AT(1a) receptor at both the mRNA and protein levels in the presence and absence of Ang II in VSMCs. Overexpression of AT(2) receptor increased expression of bradykinin and inducible NO in the presence and absence of Ang II in VSMCs. Bradykinin B(2) receptor antagonist HOE-140 and NO synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME) inhibited the decreases in AT(1a) receptor expression by the overexpression of AT(2) receptor in VSMCs. L-Arginine augmented the decrease in AT(1a) receptor expression. Overexpression of AT(2) receptor suppressed basal DNA synthesis and proliferation of VSMCs and abolished response of DNA synthesis to Ang II in VSMCs. Our results demonstrate that overexpression of the AT(2) receptor downregulates AT(1a) receptor expression in rat VSMCs in a ligand-independent manner that is mediated by the bradykinin/NO pathway. Downregulation of AT(1a) receptor is a novel mechanism by which the AT(2) receptor regulates growth and metabolism of VSMCs.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
April 2001, Hypertension (Dallas, Tex. : 1979),
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
July 2008, Arteriosclerosis, thrombosis, and vascular biology,
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.
January 1998, Life sciences,
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
March 2023, Hypertension (Dallas, Tex. : 1979),
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin II type 1a receptor null mutant mice.
August 2001, Kidney international,
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
March 2004, Cellular signalling,
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
June 2005, Clinical science (London, England : 1979),
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Splice variant-specific silencing of angiotensin II type 1a receptor messenger RNA by RNA interference in vascular smooth muscle cells.
January 2006, Biochemical and biophysical research communications,
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
March 2011, Hypertension (Dallas, Tex. : 1979),
Xue-Qing Jin, and Noboru Fukuda, and Jin-Zi Su, and Yi-Mu Lai, and Ryo Suzuki, and Yoshiko Tahira, and Hiroto Takagi, and Yukihiro Ikeda, and Katsuo Kanmatsuse, and Hitoshi Miyazaki
[Selective knockdown of Angiotensin II receptor subtype 1a in rat vascular smooth muscle cells by RNA interference].
January 2006, Zhonghua xin xue guan bing za zhi,
Copied contents to your clipboard!